Paul Tudor Jones’s SQZ Biotechnologies Company SQZ Stock Holding History

Paul Tudor Jones’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-51,998	Closed	-$711K	–	2059
2021 Q1	$711K	Buy	+51,998	New	+$1.06M	0.01%	998

Other funds holding SQZ

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Paul Tudor Jones's SQZ Position: Q2 2021 in Review

Paul Tudor Jones sold out of SQZ Biotechnologies Company (SQZ) in Q2 2021, closing a stake of 51,998 shares — an estimated $711K sold.

Paul Tudor Jones first reported a position in SQZ in Q1 2021 and held it in 1 quarter. The position peaked at $711K in Q1 2021. 49 funds tracked by Wall St. Rank hold SQZ as of Q2 2021.

Paul Tudor Jones reported no remaining SQZ Biotechnologies Company position as of Q2 2021 after selling out during the quarter.
Paul Tudor Jones sold 51,998 SQZ Biotechnologies Company shares in Q2 2021, an estimated $711K.
Paul Tudor Jones first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 1 quarter.
Paul Tudor Jones's SQZ Biotechnologies Company position peaked at $711K in Q1 2021.
49 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2021.

Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.